News | January 28, 2023
Aarti Drugs Q3 FY23 revenue grows 4%
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
The hospital will have all the modern facilities like modular OT, state of the art medical equipment, labs, etc. It will have OPD and IPD services
The company has played an important role in the procurement and distribution of emergency medical supplies supporting the Union Health Ministry for Covid–19 pandemic management
Acquisitions have the potential to add at least $1 billion in sales by 2028
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
Global pharmaceutical company having a surgical business concept incepted in Dubai
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency
Subscribe To Our Newsletter & Stay Updated
